Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Sports Medicine (Auckland, N.Z.)
|
May 1, 2007
Strategies for optimising marathon performance in the heat
David E Martin
Viruses
|
April 26, 2025
Pharmacology of Antiviral Drugs
David E Martin
Viruses
|
November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
Ralph A Tripp, David E Martin
Viruses
|
March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
Ralph A Tripp, David E Martin
Expert Opinion on Investigational Drugs
|
September 9, 2024
Antiviral agents and therapeutics against respiratory viruses
Ralph A Tripp, David E Martin
AIDS Reviews
|
November 7, 2007
Maturation inhibitors: a new therapeutic class targets the virus structure
Karl Salzwedel, David E Martin, Michael Sakalian
Antiviral Chemistry & Chemotherapy
|
November 26, 2008
Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection
David E Martin, Karl Salzwedel, Graham P Allaway
American Journal of Primatology
|
January 29, 2020
Improved method for artificial insemination in the great apes
Kenneth G Gould, David E Martin, Harold Warner
Viruses
|
November 27, 2025
Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells
Jackelyn Murray, David E Martin, Ralph A Tripp
Current Issues in Molecular Biology
|
July 23, 2025
The MAPK Response to Virus Infection Is Modified by Probenecid
Les P Jones, David E Martin, Ralph A Tripp
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Sports Medicine (Auckland, N.Z.)
|
May 1, 2007
Strategies for optimising marathon performance in the heat
David E Martin
Viruses
|
April 26, 2025
Pharmacology of Antiviral Drugs
David E Martin
Viruses
|
November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
Ralph A Tripp, David E Martin
Viruses
|
March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
Ralph A Tripp, David E Martin
Expert Opinion on Investigational Drugs
|
September 9, 2024
Antiviral agents and therapeutics against respiratory viruses
Ralph A Tripp, David E Martin
AIDS Reviews
|
November 7, 2007
Maturation inhibitors: a new therapeutic class targets the virus structure
Karl Salzwedel, David E Martin, Michael Sakalian
Antiviral Chemistry & Chemotherapy
|
November 26, 2008
Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection
David E Martin, Karl Salzwedel, Graham P Allaway
American Journal of Primatology
|
January 29, 2020
Improved method for artificial insemination in the great apes
Kenneth G Gould, David E Martin, Harold Warner
Viruses
|
November 27, 2025
Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells
Jackelyn Murray, David E Martin, Ralph A Tripp
Current Issues in Molecular Biology
|
July 23, 2025
The MAPK Response to Virus Infection Is Modified by Probenecid
Les P Jones, David E Martin, Ralph A Tripp
Page
of 7